Eli Lilly and Company
Anti-TrkA antibody

Last updated:

Abstract:

Antibodies to tropomysin receptor kinase (TrkA), compositions including such antibodies, and methods of using such antibodies for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.

Status:
Grant
Type:

Utility

Filling date:

21 Feb 2019

Issue date:

14 Apr 2020